Skip to main content

Advertisement

SpringerLink
Log in

Whither Autoimmunity: The Lessons of Anti-CCP and B cell Depletion

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

The most difficult component to understand in autoimmune disease has been the issue of causation. In contrast, there have been enormous gains in improved diagnostics as well as improved therapy. Indeed, the use of biologics have changed the profile of numerous autoimmune diseases. In this issue, we discuss two such aspects. Firstly, we place in perspective the use of anti-citrullinated protein antibodies in rheumatoid arthritis. Second, we discuss the increasing use of B cell depletion in the treatment of autoimmunity. Clinical Reviews in Allergy and Immunology is a unique venue for these themes because it covers the spectrum of allergy through autoimmunity. Indeed, we also present a special paper on the relationships of the hepatitis B virus and autoimmunity. Although the Th1 to Th2 dichotomy is well known to both murine and human immunologists, it is really in the study of specific inflammatory responses that they are correctly placed in the perspective of the continuum of immunopathology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Alessandri C, Priori R, Modesti M, Mancini R, Valesini G (2007) The role of anti-ciclic cytrullinate antibodies testing in rheumatoid arthritis. Clin Rev Allergy Immunol (in press)

  2. Bizzaro N, Tampoia M (2007) Diagnostic accuracy of immunoassays for the detection of antibodies to citrullinated proteins. Clin Rev Allergy Immunol (in press)

  3. Correia ML, Carvalho S, Fortuna J, Pereira MH (2007) Comparison of three anti-CCP antibody tests and rheumatoid factor in RA and control patients. Clin Rev Allergy Immunol (in press)

  4. Fabien N, Olsson N-O, Goetz J, Johanet C, Escande A, Bardin N, Sanmarco M, Andre C, Chevailler A, Humbel R-L, Chretien P, Monier J-C, Fortenfant F, Oksman F, Taillefer M-F, Sibilia J (2007) Prevalence of autoantibodies to cyclic citrullinated peptide in patients with rheumatic diseases other than rheumatoid arthritis: a French multicenter study. Clin Rev Allergy Immunol (in press)

  5. Nikolaos PG, Georgios TZ, Aikaterini P-T, Anastasia G, Vassiliiki GK (2007) Does the presence of anti-CCP autoantibodies and their serum levels influence the severity and activity in rheumatoid arthritis patients? Clin Rev Allergy Immunol (in press)

  6. Oliveira RD, Junta CM, Oliveira FR, Silva LM, Donadi EA, Louzada-Junior P (2007) Share epitope, citrullinated cyclic peptide antibodies and smoking in Brazilian rheumatoid arthritis patients. Clin Rev Allergy Immunol (in press)

  7. Poulsom H, Charles PJ (2007) Antibodies to citrullinated vimentin are a specific and sensitive marker for the diagnosis of rheumatoid arthritis. Clin Rev Allergy Immunol (in press)

  8. Szekanecz Z, Soos L, Szabo Z, Fekete A, Kapitany A, Vegvari A, Sipka S, Szucs G, Szanto S, Lakos G (2007) Anti-citrullinated protein antibodies in rheumatoid arthritis: As good as it gets? Clin Rev Allergy Immunol (in press)

  9. van Venrooij WJ, Zendman AJW (2007) Anti-CCP2 antibodies: an overview and perspective of the diagnostic abilities of this serological marker for early rheumatoid arthritis. Clin Rev Allergy Immunol (in press)

  10. Aouba A, Pagnoux C, Bienvenu B, Mahr A, Guillevin L (2007) Analysis of Wegener’s granulomatosis responses to rituximab: current evidence and therapeutic prospects. Clin Rev Allergy Immunol (in press)

  11. Bonara P, Vannucchi G, Campi I, Rossi S, Cantoni F, Frugoni C, Sbrozzi F, Guastella C, Avignone S, Beck-Peccoz P, Salvi M (2007) Rituximab induces distinct intraorbital and intrathyroidal effects in one patient satisfactorily treated for Graves’ ophtalmopathy. Clin Rev Allergy Immunol (in press)

  12. Carbone J, Perez-Fernandez R, Munoz A, Sabin P, Carreno L, Fernandez-Cruz E (2007) Combined therapy with Rituximab plus cyclophosphamide/vincristine/prednisone for Sjogren’s syndrome-associated B-cell non-Hodgkin’s lymphoma. Clin Rev Allergy Immunol (in press)

  13. Galarza C, Valencia D, Tobon GJ, Zurita L, Mantilla RD, Pineda-Tamayo R, Rojas-Villarraga A, Rueda JC, Anaya J-M (2007) Should Rituximab be considered as the first-choice treatment for severe autoimmune rheumatic diseases? Clin Rev Allergy Immunol (in press)

  14. Kessel A, Rosner I, Toubi E (2007) Rituximab: beyond simple B cell depletion. Clin Rev Allergy Immunol (in press)

  15. Roccatello D, Baldovino S, Rossi D, Giachino O, Mansouri M, Naretto C, Di Simone D, Francica S, Cavallo R, Alpa M, Napoli F, Sena LM (2007) Rituximab as a therapeutic tool in severe mixed cryoglobulinemia. Clin Rev Allergy Immunol (in press)

  16. Sailler L (2007) Rituximab off label use for difficult-to-treat auto-immune diseases: reappraisal of benefits and risks. Clin Rev Allergy Immunol (in press)

  17. Schmidt E, Brocker E-B, Goebeler M (2007) Rituximab in treatment-resistant autoimmune blistering skin disorders. Clin Rev Allergy Immunol (in press)

  18. Bohle B (2006) T-cell epitopes of food allergens. Clin Rev Allergy Immunol 30:97–108

    Article  PubMed  CAS  Google Scholar 

  19. Borchers AT, Chang C, Keen CL, Gershwin ME (2006) Airborne environmental injuries and human health. Clin Rev Allergy Immunol 31:1–101

    Article  PubMed  CAS  Google Scholar 

  20. Borish L, Rosenwasser L, Steinke JW (2006) Fungi in chronic hyperplastic eosinophilic sinusitis: reasonable doubt. Clin Rev Allergy Immunol 30:195–204

    Article  PubMed  CAS  Google Scholar 

  21. Bourrain JL (2006) Occupational contact urticaria. Clin Rev Allergy Immunol 30:39–46

    Article  PubMed  CAS  Google Scholar 

  22. Grob JJ, Gaudy-Marqueste C (2006) Urticaria and quality of life. Clin Rev Allergy Immunol 30:47–51

    Article  PubMed  Google Scholar 

  23. Hancox RJ (2006) Concluding remarks: can we explain the association of beta-agonists with asthma mortality? A hypothesis. Clin Rev Allergy Immunol 31:279–288

    Article  PubMed  Google Scholar 

  24. Haney S, Hancox RJ (2006) Recovery from bronchoconstriction and bronchodilator tolerance. Clin Rev Allergy Immunol 31:181–196

    Article  PubMed  CAS  Google Scholar 

  25. Hoffman DR (2006) Hymenoptera venom allergens. Clin Rev Allergy Immunol 30:109–128

    Article  PubMed  CAS  Google Scholar 

  26. Kauffman HF (2006) Innate immune responses to environmental allergens. Clin Rev Allergy Immunol 30:129–140

    Article  PubMed  CAS  Google Scholar 

  27. Kumar A, Teuber SS, Naguwa S, Prindiville T, Gershwin ME (2006) Eosinophilic gastroenteritis and citrus-induced urticaria. Clin Rev Allergy Immunol 30:61–70

    Article  PubMed  Google Scholar 

  28. Luong A, Marple BF (2006) Sinus surgery: indications and techniques. Clin Rev Allergy Immunol 30:217–222

    Article  PubMed  Google Scholar 

  29. Martinez FD (2006) Serious adverse events and death associated with treatment using long-acting beta-agonists. Clin Rev Allergy Immunol 31:269–278

    Article  PubMed  CAS  Google Scholar 

  30. Peachell P (2006) Regulation of mast cells by beta-agonists. Clin Rev Allergy Immunol 31:131–142

    Article  PubMed  CAS  Google Scholar 

  31. Salpeter SR, Buckley NS (2006) Systematic review of clinical outcomes in chronic obstructive pulmonary disease: beta-agonist use compared with anticholinergics and inhaled corticosteroids. Clin Rev Allergy Immunol 31:219–230

    Article  PubMed  CAS  Google Scholar 

  32. Schubert MS (2006) Allergic fungal sinusitis. Clin Rev Allergy Immunol 30:205–216

    Article  PubMed  Google Scholar 

  33. Taylor DR (2006) Pharmacogenetics of beta2-agonist drugs in asthma. Clin Rev Allergy Immunol 31:247–258

    Article  PubMed  CAS  Google Scholar 

  34. Hershko AY, Naparstek Y (2006) Autoimmunity in the era of genomics and proteomics. Autoimmun Rev 5:230–233

    Article  PubMed  CAS  Google Scholar 

  35. Abel K, Reneland R, Kammerer S, Mah S, Hoyal C, Cantor CR, Nelson MR, Braun A (2006) Genome-wide SNP association: identification of susceptibility alleles for osteoarthritis. Autoimmun Rev 5:258–263

    Article  PubMed  CAS  Google Scholar 

  36. Achiron A, Gurevich M (2006) Peripheral blood gene expression signature mirrors central nervous system disease: the model of multiple sclerosis. Autoimmun Rev 5:517–522

    Article  PubMed  CAS  Google Scholar 

  37. Alper CA, Husain Z, Larsen CE, Dubey DP, Stein R, Day C, Baker A, Beyan H, Hawa M, Ola TO, Leslie RD (2006) Incomplete penetrance of susceptibility genes for MHC-determined immunoglobulin deficiencies in monozygotic twins discordant for type 1 diabetes. J Autoimmun 27:89–95

    Article  PubMed  CAS  Google Scholar 

  38. Anaya JM, Castiblanco J, Tobon GJ, Garcia J, Abad V, Cuervo H, Velasquez A, Angel ID, Vega P, Arango A (2006) Familial clustering of autoimmune diseases in patients with type 1 diabetes mellitus. J Autoimmun 26:208–214

    Article  PubMed  CAS  Google Scholar 

  39. Aoki CA, Roifman CM, Lian ZX, Bowlus CL, Norman GL, Shoenfeld Y, Mackay IR, Gershwin ME (2006) IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J Autoimmun 27:50–53

    Article  PubMed  CAS  Google Scholar 

  40. Ban Y, Tozaki T, Tobe T, Ban Y, Jacobson EM, Concepcion ES, Tomer Y (2007) The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: An association analysis in Caucasian and Japanese cohorts. J Autoimmun 28:201–207

    Article  PubMed  CAS  Google Scholar 

  41. Brandt D, Gershwin ME (2006) Common variable immune deficiency and autoimmunity. Autoimmun Rev 5:465–470

    Article  PubMed  CAS  Google Scholar 

  42. Gleicher N, Barad D (2007) Gender as risk factor for autoimmune diseases. J Autoimmun 28:1–6

    Article  PubMed  CAS  Google Scholar 

  43. Abbas A, Lohr J, Knoechel B (2007) Balancing autoaggressive and protective T cell responses. J Autoimmun 28:59–61

    Article  PubMed  CAS  Google Scholar 

  44. Allina J, Hu B, Sullivan DM, Fiel MI, Thung SN, Bronk SF, Huebert RC, van de Water J, LaRusso NF, Gershwin ME, Gores GJ, Odin JA (2006) T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis. J Autoimmun 27:232–241

    Article  PubMed  CAS  Google Scholar 

  45. Alvarado-Sanchez B, Hernandez-Castro B, Portales-Perez D, Baranda L, Layseca-Espinosa E, Abud-Mendoza C, Cubillas-Tejeda AC, Gonzalez-Amaro R (2006) Regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 27:110–118

    Article  PubMed  CAS  Google Scholar 

  46. Anjos SM, Polychronakos C (2006) Functional evaluation of the autoimmunity-associated CTLA4 gene: the effect of the (AT) repeat in the 3’untranslated region (UTR). J Autoimmun 27:105–109

    Article  PubMed  CAS  Google Scholar 

  47. Ansari AA, Pereira LE, Mayne AE, Onlamoon N, Pattanapanyasat K, Mori K, Villinger F (2007) The role of disease stage, plasma viral load and regulatory T cells (Tregs) on autoantibody production in SIV-infected non-human primates. J Autoimmun 28:152–159

    Article  PubMed  CAS  Google Scholar 

  48. Conti P, Youinou P, Theoharides TC (2007) Modulation of autoimmunity by the latest interleukins (with special emphasis on IL-32). Autoimmun Rev 6:131–137

    Article  PubMed  CAS  Google Scholar 

  49. Duan B, Morel L (2006) Role of B-1a cells in autoimmunity. Autoimmun Rev 5:403–408

    Article  PubMed  CAS  Google Scholar 

  50. Fleming SD, Tsokos GC (2006) Complement, natural antibodies, autoantibodies and tissue injury. Autoimmun Rev 5:89–92

    Article  PubMed  CAS  Google Scholar 

  51. Furuzawa-Carballeda J, Vargas-Rojas MI, Cabral AR (2007) Autoimmune inflammation from the Th17 perspective. Autoimmun Rev 6:169–175

    Article  PubMed  CAS  Google Scholar 

  52. Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS (2006) Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 5:114–117

    Article  PubMed  CAS  Google Scholar 

  53. Knight AK, Cunningham-Rundles C (2006) Inflammatory and autoimmune complications of common variable immune deficiency. Autoimmun Rev 5:156–159

    Article  PubMed  CAS  Google Scholar 

  54. Le Pottier L, Devauchelle V, Pers JO, Jamin C, Youinou P (2007) The mosaic of B-cell subsets (with special emphasis on primary Sjogren’s syndrome). Autoimmun Rev 6:149–154

    Article  PubMed  Google Scholar 

  55. Akatsuka T, Kobayashi N, Ishikawa T, Saito T, Shindo M, Yamauchi M, Kurokohchi K, Miyazawa H, Duan H, Matsunaga T, Komoda T, Morisseau C, Hammock BD (2007) Autoantibody response to microsomal epoxide hydrolase in hepatitis C and A. J Autoimmun 28:7–18

    Article  PubMed  CAS  Google Scholar 

  56. Akbarali Y, Matousek-Ronck J, Hunt L, Staudt L, Reichlin M, Guthridge JM, James JA (2006) Fine specificity mapping of autoantigens targeted by anti-centromere autoantibodies. J Autoimmun 27:272–280

    Article  PubMed  CAS  Google Scholar 

  57. Asherson RA (2006) The catastrophic antiphospholipid (Asherson’s) syndrome. Autoimmun Rev 6:64–67

    Article  PubMed  Google Scholar 

  58. Atta AM, Carvalho EM, Jeronimo SM, Sousa Atta ML (2007) Serum markers of rheumatoid arthritis in visceral leishmaniasis: rheumatoid factor and anti-cyclic citrullinated peptide antibody. J Autoimmun 28:55–58

    Article  PubMed  CAS  Google Scholar 

  59. Bidoli E, Villalta D (2007) Epidemiological and ethical aspects of multiplex autoantibody testing. Autoimmun Rev 6:354–358

    Article  PubMed  Google Scholar 

  60. Binder SR, Hixson C, Glossenger J (2006) Protein arrays and pattern recognition: new tools to assist in the identification and management of autoimmune disease. Autoimmun Rev 5:234–241

    Article  PubMed  CAS  Google Scholar 

  61. Bizzaro N (2007) Autoantibodies as predictors of disease: The clinical and experimental evidence. Autoimmun Rev 6:325–333

    Article  PubMed  CAS  Google Scholar 

  62. Cavazzana I, Manuela N, Irene C, Barbara A, Sara S, Orietta BM, Angela T, Francesco T, Pier Luigi M (2007) Complement activation in anti-phospholipid syndrome: A clue for an inflammatory process? J Autoimmun 28:160–164

    Article  PubMed  Google Scholar 

  63. Chin MS, Caruso RC, Detrick B, Hooks JJ (2006) Autoantibodies to p75/LEDGF, a cell survival factor, found in patients with atypical retinal degeneration. J Autoimmun 27:17–27

    Article  PubMed  CAS  Google Scholar 

  64. Cross AK, Haddock G, Surr J, Plumb J, Bunning RA, Buttle DJ, Woodroofe MN (2006) Differential expression of ADAMTS-1, -4, -5 and TIMP-3 in rat spinal cord at different stages of acute experimental autoimmune encephalomyelitis. J Autoimmun 26:16–23

    Article  PubMed  CAS  Google Scholar 

  65. Lotito AP, Silva CA, Mello SB (2007) Interleukin-18 in chronic joint diseases. Autoimmun Rev 6:253–256

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine ‘B’ and Center for Autoimmune Diseases, Sheba Medical Center (Affiliated to Tel-Aviv University), Tel-Hashomer, 52621, Israel

    Yehuda Shoenfeld

  2. Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, 451 E. Health Sciences Drive, Suite 6510, Davis, CA, 95616, USA

    M. Eric Gershwin

Authors
  1. Yehuda Shoenfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Eric Gershwin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yehuda Shoenfeld.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shoenfeld, Y., Gershwin, M.E. Whither Autoimmunity: The Lessons of Anti-CCP and B cell Depletion. Clinic Rev Allerg Immunol 34, 1–3 (2008). https://doi.org/10.1007/s12016-007-8014-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-007-8014-5

Keywords

Search

Navigation